Cargando…

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides

Detalles Bibliográficos
Autores principales:	Tal, Perry, Eizenberger, Shay, Cohen, Elad, Goldfinger, Naomi, Pietrokovski, Shmuel, Oren, Moshe, Rotter, Varda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516712/ https://www.ncbi.nlm.nih.gov/pubmed/31191814 http://dx.doi.org/10.18632/oncotarget.26921

Ejemplares similares

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2016)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
por: Madar, Shalom, et al.
Publicado: (2013)

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
por: Sarig, Rachel, et al.
Publicado: (2010)

Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia
por: Tuval, Amos, et al.
Publicado: (2022)

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
por: Solomon, Hilla, et al.
Publicado: (2018)

p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
por: Goldstein, Ido, et al.
Publicado: (2013)

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy
por: Lonetto, Giuseppe, et al.
Publicado: (2018)

p53, a novel regulator of lipid metabolism pathways
por: Goldstein, Ido, et al.
Publicado: (2012)

Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
por: Aylon, Yael, et al.
Publicado: (2009)

Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
por: Charni-Natan, Meital, et al.
Publicado: (2018)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Mutant p53—a potential player in shaping the tumor–stroma crosstalk
por: Stein, Yan, et al.
Publicado: (2019)

p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
por: Molchadsky, Alina, et al.
Publicado: (2008)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013)

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation
por: Brosh, Ran, et al.
Publicado: (2008)

Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
por: Grespi, Francesca, et al.
Publicado: (2016)

Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
por: Shalgi, Reut, et al.
Publicado: (2009)

p53 balances between tissue hierarchy and anarchy
por: Koifman, Gabriela, et al.
Publicado: (2019)

Occurrence of protein structure elements in conserved sequence regions
por: Sitbon, Einat, et al.
Publicado: (2007)

The landscape of sex-differential transcriptome and its consequent selection in human adults
por: Gershoni, Moran, et al.
Publicado: (2017)

Corrigendum to ‘p53 balances between tissue hierarchy and anarchy’
por: Koifman, Gabriela, et al.
Publicado: (2019)

TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
por: Leshem, Orit, et al.
Publicado: (2011)

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
por: Charni, M, et al.
Publicado: (2016)

p53 on the crossroad between regeneration and cancer
por: Charni, Meital, et al.
Publicado: (2017)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

p53 and the Viral Connection: Back into the Future ‡
por: Aloni-Grinstein, Ronit, et al.
Publicado: (2018)

Correction: Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy
Publicado: (2015)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Discovery of Novel Proteasome Inhibitors Using a High-Content Cell-Based Screening System
por: Lavelin, Irena, et al.
Publicado: (2009)

Modulated expression of WFDC1 during carcinogenesis and cellular senescence
por: Madar, Shalom, et al.
Publicado: (2009)

Correction: Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP
por: Yu, Qingfen, et al.
Publicado: (2013)

ZIPK: A Unique Case of Murine-Specific Divergence of a Conserved Vertebrate Gene
por: Shoval, Yishay, et al.
Publicado: (2007)

Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)

p53: not just a tumor suppressor
por: Oren, Moshe
Publicado: (2019)

Correction: CaSTLe - Classification of single cells by transfer learning: Harnessing the power of publicly available single cell RNA sequencing experiments to annotate new experiments
por: Lieberman, Yuval, et al.
Publicado: (2018)

Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation
por: Ke, Xi-Song, et al.
Publicado: (2008)

The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice
por: Rotem, Etai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fgr78gf08lq6loef1eg4j0dpbg